This concept was previously utilized to functionally rescue folding-deficient variants of the human dopamine transporter, which trigger infantile parkinsonism/dystonia, both in vitro (heterologous cells) and in vivo (Drosophila melanogaster). Here, SLC6A3 is linked to Parkinson disease.